Your browser doesn't support javascript.
loading
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy.
Pezzini, Alessandro; Iacoviello, Licia; Di Castelnuovo, Augusto; Costanzo, Simona; Tarantino, Barbara; de Gaetano, Giovanni; Zedde, Marialuisa; Marcheselli, Simona; Silvestrelli, Giorgio; Ciccone, Alfonso; DeLodovici, Maria Luisa; Princiotta Cariddi, Lucia; Paciaroni, Maurizio; Azzini, Cristiano; Padroni, Marina; Gamba, Massimo; Magoni, Mauro; Del Sette, Massimo; Tassi, Rossana; De Franco, Ivo Giuseppe; Cavallini, Anna; Calabrò, Rocco Salvatore; Cappellari, Manuel; Giorli, Elisa; Giacalone, Giacomo; Lodigiani, Corrado; Zenorini, Mara; Valletta, Francesco; Pascarella, Rosario; Grisendi, Ilaria; Assenza, Federica; Napoli, Manuela; Moratti, Claudio; Acampa, Maurizio; Grassi, Mario.
Afiliación
  • Pezzini A; Dipartimento di Medicina e Chirurgia, Università degli Studi di Parma, Italy (A.P.).
  • Iacoviello L; Programma Stroke Care, Dipartimento di Emergenza-Urgenza, Azienda Ospedaliera Universitaria, Parma, Italy (A.P.).
  • Di Castelnuovo A; Dipartimento di Epidemiologia e Prevenzione, IRCCS Neuromed, Pozzilli, Italy (L.I., S.C., G.G.).
  • Costanzo S; Dipartimento di Medicina e Chirurgia (L.I.), Università dell'Insubria, Varese, Italy.
  • Tarantino B; Mediterranea Cardiocentro, Napoli, Italy (A.D.C.).
  • de Gaetano G; Dipartimento di Epidemiologia e Prevenzione, IRCCS Neuromed, Pozzilli, Italy (L.I., S.C., G.G.).
  • Zedde M; Dipartimento di Scienze del Sistema Nervoso e del Comportamento, Unità di Statistica Medica e Genomica, Università di Pavia, Italy (B.T., M. Grassi).
  • Marcheselli S; Stroke Unit, U.O Neurologia, IRCCS Ospedale S. Raffaele, Milano, Italy (G.G.).
  • Silvestrelli G; S.C. Neurologia, Stroke Unit (M. Zedde, I.G., F.A.), AUSL-IRCCS di Reggio Emilia, Italy.
  • Ciccone A; Neurologia d'Urgenza and Stroke Unit (S.M.), IRCCS Istituto Clinico Humanitas, Rozzano-Milano, Italy.
  • DeLodovici ML; Stroke Unit, Dipartimento di Neuroscienze, ASST Mantova, Italy (G.S., A. Ciccone).
  • Princiotta Cariddi L; Stroke Unit, Dipartimento di Neuroscienze, ASST Mantova, Italy (G.S., A. Ciccone).
  • Paciaroni M; Unità di Neurologia, Ospedale di Circolo (M.L.D.L., L.P.C.), Università dell'Insubria, Varese, Italy.
  • Azzini C; Unità di Neurologia, Ospedale di Circolo (M.L.D.L., L.P.C.), Università dell'Insubria, Varese, Italy.
  • Padroni M; Stroke Unit and Divisione di Medicina Cardiovascolare, Università di Perugia, Italy (M. Paciaroni).
  • Gamba M; Stroke Unit, Divisione di Neurologia, Dipartimento di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria di Ferrara, Italy (C.A., M. Padroni).
  • Magoni M; Stroke Unit, Divisione di Neurologia, Dipartimento di Neuroscienze e Riabilitazione, Azienda Ospedaliero-Universitaria di Ferrara, Italy (C.A., M. Padroni).
  • Del Sette M; Stroke Unit, Neurologia Vascolare, Spedali Civili di Brescia, Italy (M. Gamba, M.M.).
  • Tassi R; Stroke Unit, Neurologia Vascolare, Spedali Civili di Brescia, Italy (M. Gamba, M.M.).
  • De Franco IG; U.O. Neurologia, IRCCS Policlinico San Martino, Genova, Italy (M.D.S.).
  • Cavallini A; Stroke Unit, AOU Senese, Siena, Italy (R.T., I.G.D.F., M.A.).
  • Calabrò RS; Stroke Unit, AOU Senese, Siena, Italy (R.T., I.G.D.F., M.A.).
  • Cappellari M; UOC Malattie Cerebrovascolari e Stroke Unit, IRCCS Fondazione Istituto Neurologico Nazionale "C. Mondino," Pavia, Italy (A. Cavallini).
  • Giorli E; Istituto di Ricovero e Cura a Carattere Scientifico, Centro Neurolesi Bonino-Pulejo, Messina, Italy (R.S.C.).
  • Giacalone G; Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata Verona, Italy (M.C., M. Zenorini, F.V.).
  • Lodigiani C; U.O. Neurologia, Ospedale S. Andrea, La Spezia, Italy (E.G.).
  • Zenorini M; Dipartimento di Epidemiologia e Prevenzione, IRCCS Neuromed, Pozzilli, Italy (L.I., S.C., G.G.).
  • Valletta F; UOC Centro Trombosi e Malattie Emorragiche (C.L.), IRCCS Istituto Clinico Humanitas, Rozzano-Milano, Italy.
  • Pascarella R; Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata Verona, Italy (M.C., M. Zenorini, F.V.).
  • Grisendi I; Stroke Unit, DAI di Neuroscienze, Azienda Ospedaliera Universitaria Integrata Verona, Italy (M.C., M. Zenorini, F.V.).
  • Assenza F; SSD Neuroradiologia (R.P., M.N., C.M.), AUSL-IRCCS di Reggio Emilia, Italy.
  • Napoli M; S.C. Neurologia, Stroke Unit (M. Zedde, I.G., F.A.), AUSL-IRCCS di Reggio Emilia, Italy.
  • Moratti C; S.C. Neurologia, Stroke Unit (M. Zedde, I.G., F.A.), AUSL-IRCCS di Reggio Emilia, Italy.
  • Acampa M; SSD Neuroradiologia (R.P., M.N., C.M.), AUSL-IRCCS di Reggio Emilia, Italy.
  • Grassi M; SSD Neuroradiologia (R.P., M.N., C.M.), AUSL-IRCCS di Reggio Emilia, Italy.
Stroke ; 55(3): 634-642, 2024 Mar.
Article en En | MEDLINE | ID: mdl-38299371
ABSTRACT

BACKGROUND:

The identification of patients surviving an acute intracerebral hemorrhage who are at a long-term risk of arterial thrombosis is a poorly defined, crucial issue for clinicians.

METHODS:

In the setting of the MUCH-Italy (Multicenter Study on Cerebral Haemorrhage in Italy) prospective observational cohort, we enrolled and followed up consecutive 30-day intracerebral hemorrhage survivors to assess the long-term incidence of arterial thrombotic events, to assess the impact of clinical and radiological variables on the risk of these events, and to develop a tool for estimating such a risk at the individual level. Primary end point was a composite of ischemic stroke, myocardial infarction, or other arterial thrombotic events. A point-scoring system was generated by the ß-coefficients of the variables independently associated with the long-term risk of arterial thrombosis, and the predictive MUCH score was calculated as the sum of the weighted scores.

RESULTS:

Overall, 1729 patients (median follow-up time, 43 months [25th to 75th percentile, 69.0]) qualified for inclusion. Arterial thrombotic events occurred in 169 (9.7%) patients. Male sex, diabetes, hypercholesterolemia, atrial fibrillation, and personal history of coronary artery disease were associated with increased long-term risk of arterial thrombosis, whereas the use of statins and antithrombotic medications after the acute intracerebral hemorrhage was associated with a reduced risk. The area under the receiver operating characteristic curve of the MUCH score predictive validity was 0.716 (95% CI, 0.56-0.81) for the 0- to 1-year score, 0.672 (95% CI, 0.58-0.73) for the 0- to 5-year score, and 0.744 (95% CI, 0.65-0.81) for the 0- to 10-year score. C statistic for the prediction of events that occur from 0 to 10 years was 0.69 (95% CI, 0.64-0.74).

CONCLUSIONS:

Intracerebral hemorrhage survivors are at high long-term risk of arterial thrombosis. The MUCH score may serve as a simple tool for risk estimation.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Trombosis / Accidente Cerebrovascular / Infarto del Miocardio Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Stroke Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fibrilación Atrial / Trombosis / Accidente Cerebrovascular / Infarto del Miocardio Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Stroke Año: 2024 Tipo del documento: Article